Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acutaas ChemicalsNSE:ACUTAAS -0.57%72 Earnings Yield (Joel Greenblatt) % is 1.20% as of Jun. 2026, which is 47% below its 10-year median of 2.27. GuruFocus rates NSE:ACUTAAS with a GF Score™ of 72/100 and a GF Value™ of ₹1,374.79 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,629 Chemicals companies, Acutaas Chemicals ranks worse than 69.8% on this metric.
Acutaas Chemicals's Enterprise Value for the quarter that ended in Jun. 2026 was ₹288,694 Mil.
Acutaas Chemicals's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₹3,473 Mil. Acutaas Chemicals's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 1.20%.
The historical rank and industry rank for Acutaas Chemicals's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NSE:ACUTAAS'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.24 Med: 2.27 Max: 3.44
Current: 1.33
During the past 7 years, the highest Earnings Yield (Joel Greenblatt) of Acutaas Chemicals was 3.44%. The lowest was 1.24%. And the median was 2.27%.
NSE:ACUTAAS's Earnings Yield (Joel Greenblatt) % is ranked worse than 69.8% of 1629
companies
in the Chemicals industry
Industry Median: 3.98
vs NSE:ACUTAAS: 1.33
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Acutaas Chemicals's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Acutaas Chemicals Earnings Yield (Joel Greenblatt) % Related Terms
Acutaas Chemicals Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Acutaas Chemicals's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Acutaas Chemicals's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutaas Chemicals Earnings Yield (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Acutaas Chemicals's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Acutaas Chemicals's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Acutaas Chemicalss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2025 is calculated as
Acutaas Chemicals's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,473 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 1.20% mean?
Acutaas Chemicals (NSE:ACUTAAS) has a Earnings Yield (Joel Greenblatt) % of 1.20% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Acutaas Chemicals and its competitors. This is 47% below median its historical median of 2.27. Over the past decade, Acutaas Chemicals' Earnings Yield (Joel Greenblatt) % has ranged from 1.24 to 3.44. According to the industry distribution chart, Acutaas Chemicals ranks #1137 out of 1629 companies in the Chemicals industry, placing it in the top 69.8%.
Is Acutaas Chemicals' Earnings Yield (Joel Greenblatt) % too high?
Acutaas Chemicals' current Earnings Yield (Joel Greenblatt) % of 1.20% is 47% below median its 10-year median of 2.27. Over the past 10 years, this metric has ranged from a low of 1.24 to a high of 3.44. The Chemicals industry median Earnings Yield (Joel Greenblatt) % is 3.98. Acutaas Chemicals' value of 1.20% is 69.8% below this industry median. Based on the distribution chart, Acutaas Chemicals ranks #1137 out of 1629 companies in the Chemicals industry, which is below the industry midpoint. Overall, Acutaas Chemicals has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acutaas Chemicals' Earnings Yield (Joel Greenblatt) % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Acutaas Chemicals ranks #1137 out of 1629 companies for Earnings Yield (Joel Greenblatt) %. This places Acutaas Chemicals in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.98. Acutaas Chemicals' value of 1.20% is 69.8% below this benchmark. Historically, Acutaas Chemicals' own Earnings Yield (Joel Greenblatt) % has ranged from 1.24 to 3.44 over the past decade. While the company's 10-year median is 2.27 vs. the industry median of 3.98, Acutaas Chemicals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Chemicals company?
The median Earnings Yield (Joel Greenblatt) % among Chemicals companies is 3.98, based on 1,629 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acutaas Chemicals's current Earnings Yield (Joel Greenblatt) % of 1.20% is 69.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Acutaas Chemicals and its competitors. For the Chemicals industry, the median Earnings Yield (Joel Greenblatt) % is 3.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acutaas Chemicals's current Earnings Yield (Joel Greenblatt) % is 1.20%, which is 47% below median its own 10-year median of 2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutaas Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Acutaas Chemicals (NSE:ACUTAAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,374.79, compared to a current price of ₹3,210.50 — trading 133.5% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 1.20%, which is 47% below median its 10-year median of 2.27 and 69.8% below the Chemicals industry median of 3.98. Acutaas Chemicals' overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Acutaas Chemicals (NSE:ACUTAAS), the current Earnings Yield (Joel Greenblatt) % is 1.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?
Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued.
The current stock price of ₹3,210.50 is trading 133.5% above its estimated GF Value™ of ₹1,374.79.
GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.
Key valuation signals for NSE:ACUTAAS:
Earnings Yield (Joel Greenblatt) %: 1.20% (47% below median its 10-year median of 2.27)
GF Value™: ₹1,374.79 vs. price of ₹3,210.50 (133.5% above fair value)
Industry Position: 69.8% below the Chemicals median (#1137 of 1629)
No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
72GF Score
Get the complete analysis for NSE:ACUTAAS
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACUTAAS has been successfully added to your 
